Shell Asset Management CO Pacira Bio Sciences, Inc. Transaction History
Shell Asset Management CO
- $2.9 Billion
- Q2 2025
A detailed history of Shell Asset Management CO transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 1,786 shares of PCRX stock, worth $38,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,786
Previous 1,957
8.74%
Holding current value
$38,184
Previous $49,000
12.24%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
51MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$171 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$116 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$51.2 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$48.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$46 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $980M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...